Bipolar II Disorder: Current and Future Treatment Options

References

• Baldassano CF, Datto SM, Littman L, Lipari MA: What drugs are best for bipolar depression? Ann Clin Psychiatry 2003; 15: 225–232
   Google Scholar
• Keck PE, Jr., Nelson EB, McElroy SL: Advances in the pharmacologic treatment of bipolar depression. Biol Psychiatry 2003; 53:671–679
   Google Scholar
• Dunner DL, Stallone F, Fieve RR: Lithium carbonate and affective disorders. V: A double-blind study of prophylaxis of depression in bipolar illness. Arch Gen Psychiatry 1976; 33:117–120
   Google Scholar
• Dunner DL, Gershon ES, Goodwin FK: Heritable factors in the severity of affective illness. Biol Psychiatry 1976; 11:31–42
   Google Scholar
• American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. 2000
   Google Scholar
• Gershon ES, Hamovit J, Guroff JJ et al.: A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry 1982; 39:1157–1167
   Google Scholar
• Heun R, Maier W: The distinction of bipolar II disorder from bipolar I and recurrent unipolar depression: Results of a controlled family study. Acta Psychiatr Scand 1993; 87:279–284
   Google Scholar
• Heun R, Maier W: Bipolar II disorders in six first-degree relatives. Biol Psychiatry 1993; 34:274–276
   Google Scholar
• Simpson SG, Folstein SE, Meyers DA et al.: Bipolar II: The most common bipolar phenotype? Am J Psychiatry 1993; 150: 901–903
   Google Scholar
• Hirschfeld RM, Calabrese JR, Weissman MM et al.: Screening for bipolar disorder in the community. J Clin Psychiatry 2003; 64:53–59
   Google Scholar
• Judd LL, Akiskal HS: The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord 2003; 73:123–131
   Google Scholar
• Ghaemi SN, Sachs GS, Chiou AM, Pandurangi AK, Goodwin K: Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? J Affect Disord 1999; 52:135–144
   Google Scholar
• Smith DJ, Harrison N, Muir W, Blackwood DH: The high prevalence of bipolar spectrum disorders in young adults with recurrent depression: Toward an innovative diagnostic framework. J Affect Disord 2005; 84:167–178
   Google Scholar
• Judd LL, Akiskal HS, Schettler PJ et al.: A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003; 60:261–269
   Google Scholar
• Coryell W, Endicott J, Maser JD et al.: Long-term stability of polarity distinctions in the affective disorders. Am J Psychiatry 1995; 152:385–390
   Google Scholar
• Faedda GL, Tondo L, Baldessarini RJ, Suppes T, Tohen M: Outcome after rapid vs. gradual discontinuation of lithium treatment in bipolar disorders. Arch Gen Psychiatry 1993; 50:448–455
   Google Scholar
• Angst J, Gamma A, Benazzi F et al.: Toward a re-definition of subthreshold bipolarity: Epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J Affect Disord 2003; 73:133–146
   Google Scholar
• Akiskal HS, Pinto O: The evolving bipolar spectrum. Prototypes I, II, III, and IV. Psychiatr Clin North Am 1999; 22:517–534, vii
   Google Scholar
• Perugi G, Akiskal HS: The soft bipolar spectrum redefined: Focus on the cyclothymic, anxious-sensitive, impulse-dyscontrol, and binge-eating connection in bipolar II and related conditions. Psychiatr Clin North Am 2002; 25:713–737
   Google Scholar
• Ghaemi SN, Boiman EE, Goodwin FK: Diagnosing bipolar disorder and the effect of antidepressants: A naturalistic study. J Clin Psychiatry 2000; 61:804–808
   Google Scholar
• Kupfer DJ, Frank E, Grochocinski VJ et al.: Demographic and clinical characteristics of individuals in a bipolar disorder case registry. J Clin Psychiatry 2002; 63:120–125
   Google Scholar
• Rihmer Z, Kiss K: Bipolar disorders and suicidal behaviour. Bipolar Disord 2002; 4 Suppl. 1:21–25
   Google Scholar
• Benazzi F: Toward better probing for hypomania of bipolar-II disorder by using Angst–s checklist. Int J Methods Psychiatr Res 2004; 13:1–9
   Google Scholar
• Amsterdam J: Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode. J Clin Psychopharmacol 1998; 18:414–417
   Google Scholar
• Amsterdam JD, Garcia-Espana F, Fawcett J et al.: Efficacy and safety of fluoxetine in treating bipolar II major depressive episode. J Clin Psychopharmacol 1998; 18:435–440
   Google Scholar
• Amsterdam JD, Garcia-Espana F: Venlafaxine monotherapy in women with bipolar II and unipolar major depression. J Affect Disord 2000; 59:225–229
   Google Scholar
• Calabrese JR, Suppes T, Bowden CL et al.: A double-blind, placebo- controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 2000; 61: 841–850
   Google Scholar
• Ghaemi SN, Katzow JJ, Desai SP, Goodwin FK: Gabapentin treatment of mood disorders: A preliminary study. J Clin Psychiatry 1998; 59:426–429
   Google Scholar
• Tondo L, Baldessarini RJ, Floris G, Rudas N: Effectiveness of restarting lithium treatment after its discontinuation in bipolar I and bipolar II disorders. Am J Psychiatry 1997; 154:548–550
   Google Scholar
• Tondo L, Baldessarini RJ, Hennen J, Floris G: Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders. Am J Psychiatry 1998; 155:638–645
   Google Scholar
• Tondo L, Baldessarini RJ, Floris G: Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders. Br J Psychiatry 2001; 178(Suppl.):S184–S190
   Google Scholar
• Calabrese JR, Keck PE Jr, Macfadden W et al.: A randomized, double- blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005; 162(7):1351– 1360
   Google Scholar
• Hirschfeld RM, Weisler RH, Raines SR, Macfadden W, for the BOLDER Study Group: Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: A secondary analysis from a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2006; 67(3):355–362
   Google Scholar
• Vieta E, Gasto C, Colom F et al.: Role of risperidone in bipolar II: An open 6-month study. J Affect Disord 2001; 67:213–219
   Google Scholar
• Vieta E, Sanchez-Moreno J, Goikolea JM et al.: Adjunctive topiramate in bipolar II disorder. World J Biol Psychiatry 2003; 4:172–176
   Google Scholar
• Winsberg ME, DeGolia SG, Strong CM, Ketter TA: Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression. J Affect Disord 2001; 67:207–212
   Google Scholar
• Zarate CA, Jr., Payne JL, Singh J et al.: Pramipexole for bipolar II depression: a placebo-controlled proof of concept study. Biol Psychiatry 2004; 56:54–60
   Google Scholar
• Dilsaver SC, Swann SC, Chen YW et al.: Treatment of bipolar depression with carbamazepine: Results of an open study. Biol Psychiatry 1996; 40:935–937
   Google Scholar
• Kupfer DJ, Chengappa KN, Gelenberg AJ et al.: Citalopram as adjunctive therapy in bipolar depression. J Clin Psychiatry 2001; 62:985–990
   Google Scholar
• Perugi G, Toni C, Ruffolo G, Frare F, Akiskal H: Adjunctive dopamine agonists in treatment-resistant bipolar II depression: An open case series. Pharmacopsychiatry 2001; 34:137–141
   Google Scholar
• Silverstone T: Moclobemide vs. imipramine in bipolar depression: A multicentre double-blind clinical trial. Acta Psychiatr Scand 2001; 104:104–109
   Google Scholar
• Bowden CL, Calabrese JR, Sachs G et al.: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003; 60:392–400
   Google Scholar
• Calabrese JR, Bowden CL, Sachs G et al.: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003; 64:1013–1024
   Google Scholar
• Hartong EG, Moleman P, Hoogduin CA, Broekman TG, Nolen WA: Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients. J Clin Psychiatry 2003; 64:144–151
   Google Scholar
• Stokes PE, Shamoian CA, Stoll PM, Patton MJ: Efficacy of lithium as acute treatment of manic-depressive illness. Lancet 1971; 1:1319–1325
   Google Scholar
• Calabrese JR, Bowden CL, Sachs GS et al.: A double-blind placebo- controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 1999; 60: 79–88
   Google Scholar
• Goodwin GM, Bowden CL, Calabrese JR et al.: A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 2004; 65: 432–441
   Google Scholar
• Frye MA, Ketter TA, Kimbrell TA et al.: A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000; 20:607–614
   Google Scholar
• Powers P, Sachs GS, Kushner S et al.: Topiramate in adults with acute bipolar I mania: Pooled results. Presented at 157th American Psychiatric Association Annual Meeting, May 1–6, 2004, New York, NY
   Google Scholar
• Kleindienst N, Greil W: Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study. Neuropsychobiology 2000; Suppl. 1:2–10
   Google Scholar
• Greil W, Kleindienst N, Erazo N, Muller-Oerlinghausen B: Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. J Clin Psychopharmacol 1998; 18: 455–460
   Google Scholar
• Weisler RH, Kalali AH, Ketter TA, and the SPD417 Study Group: A multicenter, randomized, double-blind, placebocontrolled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 2004; 65:478–484
   Google Scholar
• Weisler RH, Keck PE, Swann AC et al.: Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: A multicenter, randomized, double-blind, placebocontrolled trial. J Clin Psychiatry 2005; 66:323–330
   Google Scholar
• Suppes T, Hirschfeld RM, Carlsson A, Stening G, Vieta E: Quetiapine monotherapy for depressive episodes of bipolar II disorder: combined results from two placebo-controlled studies. Presented at 159th American Psychiatric Association Annual Meeting May 20–25, 2006, Toronto, Canada
   Google Scholar
• Weisler RH, Macfadden W, Arvekvist R, Stening G et al.: Efficacy of quetiapine monotherapy in bipolar I depression: combined results from two double-blind, placebo-controlled studies. Presented at 159th American Psychiatric Association Annual Meeting May 20–25, 2006, Toronto, Canada
   Google Scholar
• Henry C, Demotes-Mainard J: Avoiding drug-induced switching in patients with bipolar depression. Drug Saf 2003; 26:337–351
   Google Scholar
• Moller HJ, Nasrallah HA: Treatment of bipolar disorder. J Clin Psychiatry 2003; 64 Suppl. 6:9–17
   Google Scholar
• Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherty JP: The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. Postgrad Med 2000; Spec No:1–104
   Google Scholar
• Thase ME, Bhargava M, Sachs GS: Treatment of bipolar depression: Current status, continued challenges, and the STEP-BD approach. Psychiatr Clin North Am 2003; 26:495–518.
   Google Scholar
• Berk M, Segal J, Janet L, Vorster M: Emerging options in the treatment of bipolar disorders. Drugs 2001; 61:1407–1414
   Google Scholar
• Rush AJ, George MS, Sackeim HA et al.: Vagus nerve stimulation (VNS) for treatment-resistant depressions: A multicenter study. Biol Psychiatry 2000; 47:276–286
   Google Scholar
• Leibenluft E, Turner EH, Feldman-Naim S et al.: Light therapy in patients with rapid cycling bipolar disorder: preliminary results. Psychopharmacol Bull 1995; 31:705–710.
   Google Scholar
• Colom F, Vieta E, Martinez-Aran A et al.: A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry 2003; 60:402–407
   Google Scholar
• Bowden CL, Brugger AM, Swann AC et al.: Efficacy of divalproex vs. lithium and placebo in the treatment of mania. JAMA 1994; 271:918–924
   Google Scholar
• Emilien G, Maloteaux JM, Seghers A, Charles G: Lithium compared to valproic acid and carbamazepine in the treatment of mania: A statistical meta-analysis. Eur Neuropsychopharmacol 1996; 6:245–252
   Google Scholar
• O–Connell RA, Mayo JA, Flatow L, Cuthbertson B, O–Brien BE: Outcome of bipolar disorder on long-term treatment with lithium. Br J Psychiatry 1991; 159:123–129
   Google Scholar
• Weisler RH, Hirschfeld R, Cutler AJ et al.: Efficacy of extendedrelease carbamazepine in bipolar disorder: Results of two pooled clinical trials. Presented at U.S. Psychiatric and Mental Health Congress, November 18–21, 2004, San Diego, CA
   Google Scholar